GKOS
Glaukos Corp
NYSE: GKOS · HEALTHCARE · MEDICAL DEVICES
$116.96
-2.23% today
Updated 2026-04-29
Market cap
$7.00B
P/E ratio
—
P/S ratio
13.80x
EPS (TTM)
$-3.28
Dividend yield
—
52W range
$73 – $130
Volume
0.7M
Glaukos Corp (GKOS) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.43M | $20.95M | $45.59M | $71.70M | $114.40M | $159.25M | $181.28M | $236.98M | $224.96M | $294.01M | $282.86M | $314.71M | $383.48M | $507.44M |
| Revenue growth (YoY) | — | +762.3% | +117.6% | +57.3% | +59.5% | +39.2% | +13.8% | +30.7% | -5.1% | +30.7% | -3.8% | +11.3% | +21.9% | +32.3% |
| Cost of revenue | $1.66M | $2.54M | $11.42M | $12.99M | $16.18M | $21.05M | $25.07M | $38.59M | $91.72M | $66.63M | $68.98M | $75.58M | $94.03M | $224.68M |
| Gross profit | $774000.00 | $18.41M | $34.17M | $58.71M | $98.22M | $138.20M | $156.20M | $198.40M | $133.24M | $227.38M | $213.88M | $239.14M | $289.45M | $282.76M |
| Gross margin | 31.9% | 87.9% | 75.0% | 81.9% | 85.9% | 86.8% | 86.2% | 83.7% | 59.2% | 77.3% | 75.6% | 76.0% | 75.5% | 55.7% |
| R&D | $13.30M | $15.51M | $19.20M | $25.05M | $29.22M | $38.91M | $49.68M | $68.31M | $85.39M | $101.00M | $123.27M | $138.77M | $136.43M | $150.61M |
| SG&A | $8.97M | $16.60M | $27.73M | $43.16M | $63.16M | $94.16M | $119.53M | $174.13M | $169.80M | $178.06M | $190.43M | $222.57M | $259.25M | $331.75M |
| Operating income | $-22.10M | $-14.20M | $-13.17M | $-10.30M | $4.24M | $-2.28M | $-13.00M | $-50.29M | $-123.55M | $-32.87M | $-82.31M | $-128.70M | $-122.37M | $-199.60M |
| Operating margin | -909.8% | -67.8% | -28.9% | -14.4% | 3.7% | -1.4% | -7.2% | -21.2% | -54.9% | -11.2% | -29.1% | -40.9% | -31.9% | -39.3% |
| EBITDA | $-21.46M | $-12.76M | $-8.93M | $-32.96M | $8.96M | $5.48M | $-6.74M | $-37.61M | $-83.59M | $-1.47M | $-48.76M | $-82.12M | $-95.64M | $-150.31M |
| EBITDA margin | -883.5% | -60.9% | -19.6% | -46.0% | 7.8% | 3.4% | -3.7% | -15.9% | -37.2% | -0.5% | -17.2% | -26.1% | -24.9% | -29.6% |
| EBIT | $-22.10M | $-13.91M | $-13.16M | $-37.23M | $4.24M | $1000.00 | $-13.00M | $-47.47M | $-118.20M | $-35.90M | $-84.71M | $-120.09M | $-135.56M | $-188.41M |
| Interest expense | — | $307000.00 | $876000.00 | $1.06M | $608000.00 | $44000.00 | $0.00 | $2.56M | $14.12M | $13.37M | $13.72M | $13.63M | $10.04M | $4.63M |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-19.33M | $-12.64M | $-12.13M | $-37.24M | $4.52M | $-92000.00 | $-12.95M | $15.42M | $-120.35M | $-49.59M | $-99.19M | $-134.66M | $-146.37M | $-187.69M |
| Net income growth (YoY) | — | +34.6% | +4.1% | -207.1% | +112.1% | -102.0% | -13977.2% | +219.1% | -880.3% | +58.8% | -100.0% | -35.8% | -8.7% | -28.2% |
| Profit margin | -795.8% | -60.3% | -26.6% | -51.9% | 4.0% | -0.1% | -7.1% | 6.5% | -53.5% | -16.9% | -35.1% | -42.8% | -38.2% | -37.0% |